News & Notes
March 13, 2019
ACMS Elects Four New Board Members
The ACMS recently elected four new members to the Board of Directors. Dr. Clark Otley of Mayo Clinic in Rochester, Minnesota; Dr. Daniel Eisen of the University of California, Davis Medical Center, Dr. Eva Hurst of Washington University St. Louis School of Medicine and Dr. Michel McDonald of Vanderbilt University will transition on to the ACMS Board of Directors at the 2019 Annual Meeting in Baltimore, taking place May 2-5, 2019.
Dr. Otley begins his one-year term as Secretary/Treasurer before transitioning to Vice President at the 2020 Annual Meeting, after which he will serve as President of the ACMS in 2021. Drs. Eisen, Hurst and McDonald will serve as Directors on the Board until 2022. Learn more about each member below.
On behalf of the entire College membership, ACMS President Dr. Barry Leshin expresses his deep appreciation and sincere thanks for the tireless enthusiasm exhibited by all of the outgoing Board Members. Drs. Jerry Brewer, Scott Collins, and Howard Rogers will leave a legacy of exemplary work ethic and principled commitment to the success of the College.
To everyone who participated in this election; to each candidate who accepted nominations, and to all who voted, thank you for helping to shape the future of your organization.
Clark C. Otley, MD, FACMS • Secretary/Treasurer
Dr. Otley works in the Department of Dermatology at Mayo Clinic, as well as the Mayo Clinic College of Medicine and Science, in Rochester, Minnesota. He completed medical school at Duke, and his residency and fellowship training at Harvard and Mayo Clinic respectively. Dr. Otley was the Founding President of the International Transplant Skin Cancer Collaborative and has served on a number of ACMS committees including chairing the Frederic E. Mohs Award Committee.
Daniel B. Eisen, MD, FACMS • Board Member
Dr. Eisen is affiliated with the University of California Davis Medical Center. After completing medical school at Hahnemann University School of Medicine, he completed his dermatology residency and fellowship training at Washington Hospital Center and University of British Columbia respectively. Dr. Eisen currently serves on the ACMS Quality Slide Review Committee and is very active in the Association of Professors of Dermatology. Additionally, he remains very involved with the AAD, APD and the Hidradenitis Suppurativa Foundation, Inc. (HSF).
Eva A. Hurst, MD, FACMS • Board Member
Dr. Hurst is an Associate Professor of Medicine (Division of Dermatology), Director of Dermatologic Surgery, Director of Clinical Operations for the Division of Dermatology and Director of Micrographic Surgery and Dermatologic Oncology Fellowship at Washington University in St. Louis School of Medicine. After completing medical school from Washington University in St. Louis School of Medicine, Dr. Hurst completed her residency at the University of California, San Francisco. She also finished her fellowship training program at UCSF. Dr. Hurst has been active in the AAD, ASDS, and WDS and has served on a number of ACMS committees, including the National Registry and Outcomes Database Subcommittee and Newsletter Committee.
Michel A. McDonald, MD, FACMS • Board Member
Dr. McDonald is the Director of Dermatologic Surgery at Vanderbilt University Medical Center. After attending medical school at the University of Louisville, she completed both her residency and fellowship training at Vanderbilt University Medical Center. Dr. McDonald has served the ACMS as Chair of the Scientific Program Committee as well as a member of the Public Policy Committee. She has also represented the ACMS as a delegate to the American Medical Association. Dr. McDonald is an active member of the AAD and has been active with both ASDS and WDS.
March 13, 2019
Episode 5 of ACMS Podcast Now Available
A new episode of the College’s podcast series, Conversations in Mohs Surgery, is now available at www.mohscollege.org/podcast. Host Dr. Thomas Knackstedt interviews Dr. Christopher J. Miller, MD, FACMS, Director of the Penn Dermatology Oncology Center and Associate Professor of Dermatology at the Hospital of the University of Pennsylvania. Dr. Miller discusses two recent studies, Melanomas of the head and neck have high local recurrence risk features and require tissue rearranging reconstruction more commonly than BCC and SCC: A comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors and The 'Rule of 10s' versus the 'Rule of 2s': High complication rates after conventional excision with postoperative margin assessment of specialty site versus trunk and proximal extremity melanomas. Both were published in the Journal of the American Academy of Dermatology in late 2018.
In addition to listening on the ACMS website, subscribe to the podcast via iTunes/Apple Podcasts and Google Play Music by searching ACMS Podcast and tapping the Subscribe button. Please take a moment to rate and review the podcast. Listen here.
December 17, 2018
Winter Membership Bulletin e-Newsletter
The Winter 2018 issue of the ACMS Membership Bulletin e-newsletter is now available. Read it here.
In This Issue
- President’s Message
- Viewpoint: Update on Board Certification for Micrographic Dermatologic Surgery
- ACMS Happenings
- Call for Mohs Award Nominations
- ACMS Meets USP Regarding In-Office Compounding
- ACMS Foundation Marks Progress, Builds Structure
- Send Your Tech to Mohs Technician Quality Assurance Training January 24-25
- Ask Glenn: Answers to Your Mohs Coding & Billing Questions
- Hot Topic: Fire Prevention in Mohs Surgery
- Practice Tips and Efficacy: The Utility of Patient Education Videos Prior to Informed Consent for Mohs Surgery
- Highlights from the Literature: Mohs for Invasive Melanoma/AUC Updates
- Fellow-in-Training Perspectives: Use of Digital Patient Photography for Surgical Site Identification
October 30, 2018
ABMS Approves Subspecialty Certification in MDS
The American Board of Dermatology (ABD) has announced that The American Board of Medical Specialties (ABMS) approved the creation of subspecialty certification in Micrographic Dermatologic Surgery (MDS).
We deeply appreciate the strong support of this initiative by our own members, and by numerous other specialty organizations and ABMS member boards. We are also grateful for the remarkable dedication of Drs. Randy Roenigk and Tom Stasko. Their thoughtful and steadfast leadership was instrumental in garnering this momentous recognition. We are hopeful that the divisions within our specialty during the recent comment period will diminish as we experience the positive impact of this certification pathway.
We will continue to communicate with you as we learn more details regarding the certification process. Rest assured the College will be developing an educational program to have you well-prepared for the board examination. Again, we would like to express our gratitude for your pivotal role in supporting this milestone, which has long been a pillar of the College’s Strategic Plan.
Barry Leshin, MD, FACMS, President
Elizabeth Billingsley, MD, FACMS, Vice President
Glenn Goldman, MD, FACMS, Secretary/Treasurer
Allison Vidimos, MD, FACMS, Immediate Past President
October 17, 2018
ACMS Seeks Change to Proposed Compounding Guidelines
The ACMS joins the American Academy of Dermatology in its efforts to ask that the USP adopt at least a 12-hour exemption from its safety equipment and process standards in Chapter 797 affecting compounded sterile preparations. The content below is provided by the AAD and can be accessed on the AAD website here.
On July 27, the United States Pharmacopeial Convention (USP) published its second set of proposed revisions to its General Chapter <797> Pharmaceutical Compounding – Sterile Preparations. Chapter 797 sets forth standards for compounding sterile preparations, including performing manipulations inside a certified ISO 5 area, conducting routine environmental monitoring, and conducting personnel sampling (including glove fingertip sampling). This chapter affects CSPs in dermatology, such as buffered lidocaine (lidocaine with or without epinephrine mixed with sodium bicarbonate), reconstituted botulinum toxins (bacteriostatic saline instead of normal saline), and diluted triamcinolone acetonide.
In its proposed revisions, the USP proposes a one-hour time exemption from the chapter’s standards for in-office preparations, starting with preparation and ending with administration of the CSP. While this is an improvement from the current standards that have no exemptions applicable to dermatology, limiting the exemption to one hour is insufficient. The one-hour exemption would not cover buffering lidocaine at the beginning of the workday to be used throughout the day or ahead of a surgery that lasts longer than an hour. Without a longer exemption, patient access to buffered lidocaine, reconstituted botulinum toxins and diluted triamcinolone acetonide will be impeded.
As dermatologists, our utmost concerns are quality patient care and patient safety. To treat their skin cancers and numerous skin diseases, patients require access to medications prepared and administered in the clinical setting. A longer exemption is needed for buffering lidocaine, which is a common practice in dermatology. Sodium bicarbonate is added to lidocaine with epinephrine using aseptic technique to neutralize the pH of the preparation from approximately 4 to approximately 7.4 in a process called “buffering” to decrease the pain of the injection and increase the onset of the local anesthesia. Having buffered lidocaine syringes prepared in advance of patient visits at the beginning of the day is critical for uninterrupted patient access. Peer-reviewed scientific studies support this practice. We are concerned that physicians would need to step away from caring for patients to buffer lidocaine or comply with the chapter’s standards, which are unreasonably burdensome for a low-risk preparation created by mixing two FDA-approved drugs. For all these reasons, we respectfully request that the USP increase the time-based exemption proposed to at least 12 hours to accommodate the preparation of compounded sterile preparations at the beginning of the day.
If you have any questions about USP’s proposed revisions to General Chapter <797> Pharmaceutical Compounding – Sterile Preparations, please contact Natasha Pattanshetti, Manager, Regulatory Policy at firstname.lastname@example.org.
The President's Message is sent monthly via email to ACMS members.
- Read current and past President's Messages (member login required)
Member Research Surveys
From its inception, an essential role of the Mohs College has been to help fellowship trainees become the best Mohs surgeons possible through rigorous fellowship training programs, and in the process advance knowledge in the specialty. Supporting the research they undertake during their fellowships is an important part of their education and development. To support this, open surveys linked to research studies conducted by residents, fellows-in-training and College members are distributed in a monthly email to members. These surveys have been reviewed and approved for distribution by the Executive Committee of the ACMS Board of Directors.
The Cutting Edge
The Cutting Edge provides important ACMS news alongside the latest updates relevant Mohs surgeons. Delivered biweekly via email, this news brief includes scannable summaries of more detailed content available on the ACMS website and elsewhere.
Please note that The Cutting Edge is sent as an email from email@example.com. Please add this domain to your safe senders list to ensure delivery.
Each year's Fellow-in-Training Board Observer also serves as a member of the ACMS Newsletter Committee, in order to participate in discussion of, and provide valuable perspective on, College activities and news for other fellows-in-training.
The ACMS is proud to underscore the high caliber of its members by featuring their professional and scientific achievements, including publications, presentations, awards and other recognition. To help us share your achievement, complete the submission form below with as much information as possible. You may also upload any relevant or supporting documents.
- Publications: Include journal title, publication date, title of your entry, any co-authors, etc.
- Presentations: Include presentation title, date, conference/workshop name, venue, city, state, any co-presenters, etc.
- Awards: Include name of entity bestowing award, what you were awarded/honored for, any relevant award criteria, when and where award was given (date, venue, city, state), etc.
- If applicable, include web links that provide context or contain more information about your achievement.
- Include a headshot to accompany the news item online.
- Please spell out any acronyms or other terminology that may be unfamiliar to readers.
Feel free to contact the ACMS Office at firstname.lastname@example.org or (414) 347-1103 with any questions.